2024 annual financial data
Rani Therapeutics Holdings 2024 Operating cash flow
Direct answer
Operating cash flow was -35,496,000 USD.
Operating income was -53,314,000 USD and net income was -30,018,000 USD.
Operating cash flow was -35,496,000 USD.
Get free Rani Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,028,000 USD
- Operating income
- -53,314,000 USD
- Net income
- -30,018,000 USD
- Operating cash flow
- -35,496,000 USD